5,34 €
- Dez.
- März
- Juni
- Sept.
- Dez.
- 5.30
- 6.90
- 8.60
- 10.20
- 11.80
ERTRÄGE
Warnung: Die Dividende wurde um 41,2% gekürzt auf 0,21 € pro Aktie. Dies könnte eine strategische Entscheidung sein oder auf veränderte finanzielle Prioritäten hinweisen. Aktionäre sollten prüfen, ob dies ein isolierter Rückschlag oder ein Zeichen struktureller Probleme ist.
0,21 €
Jährliche Dividende
3,89 %
Rendite
-41,22 %
Dividenden-Wachstum
3,87 %
Ausschüttungsquote
UNTERNEHMEN
Mehr Insights mit HolisticLENS Jetzt upgraden!
22,0 Mrd. ZAR
Umsatz
-50,88 %
Umsatz-Wachstum
2,4 Mrd. ZAR
Nettogewinn
-
2,8 %
ROE -
10,9 %
ROS -
1,8 %
ROA -
22,5 %
GPM
1,8 Mrd. ZAR
Operativer Cashflow
85,0 Mrd. ZAR
Eigenkapital
8.867
Mitarbeiter
-
2,5 Mio. ZAR
Umsatz / MA -
269.313,2 ZAR
Gewinn / MA
KGV
22,69 ZARKBV
0,64 ZARKCV
89,10 ZARKUV
2,47 ZAREV/EBITDA
20,03 ZAREV/EBIT
8.984,06 ZAREV/FCF
162,54 ZAREV/Umsatz
4,50 ZAREnterpriseValue
98,8 Mrd. ZAREigenkapitalrendite
2,81 %Umsatzrendite
10,87 %EBIT-Marge
0,05 %EBITDA-Marge
22,47 %Kapitalumschlag
0,16 ZARGesamtkapitalrendite
1,75 %Eigenkapitalquote
0,62 ZARFremdkapitalquote
0,38 ZARVerschuldungsgrad
0,60 ZARDyn. Verschuldungsgrad
28,40 ZARSachinvestitionsquote
-0,66 ZARAnlagendeckungsgrad 1
1,14 ZARAnlagendeckungsgrad 2
0,81 ZARLiquidität 1. Grades
0,38 ZARLiquidität 2. Grades
1,15 ZARLiquidität 3. Grades
2,28 ZARDividende pro Aktie
0,21 ZARDividendenrendite
0,17 %Ausschüttungsquote
3,87 %Buchwert pro Aktie
191,37 ZARCashflow pro Aktie
4,06 ZARStand: 30.06.2025 TTM
Fakten
-
Sitz
Südafrika
-
Hauptsitz
Durban
-
Börsengang
29.04.2010
-
Ausstehende Aktien
444,10 Mio.
-
Mitarbeiter
8,87 Tsd.
-
Währung
ZAR
-
Sektor
Gesundheitswesen
-
Industrie
Drug Manufacturers - Specialty & Generic
-
Börse
OTC
-
Ticker
APNHF
-
Webseite
Aktie
Unternehmensinfos
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.